Residency · Washington, DC
Sponsored by George Washington University School of Medicine
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024 · 297 citations · Jonathan Silverberg
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Journal of the American Academy of Dermatology · 2024 · 210 citations · Jonathan Silverberg
North American Contact Dermatitis Group Patch Test Results: 2019-2020.
Dermatitis : contact, atopic, occupational, drug · 2023 · 104 citations · Amber Atwater, Jonathan Silverberg
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
The New England journal of medicine · 2023 · 275 citations · Jonathan Silverberg
Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021 · 349 citations · Jonathan Silverberg
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
The New England journal of medicine · 2021 · 364 citations · Jonathan Silverberg
Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
Journal of the American Academy of Dermatology · 2023 · 164 citations · Jonathan Silverberg
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Lancet (London, England) · 2024 · 117 citations · Jonathan Silverberg